Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.
第一作者:
Tomohiro,Okawa
第一单位:
Shonan Research Center, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd. , 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
作者:
医学主题词
结晶学, X线(Crystallography, X-Ray);细胞色素P-450 CYP3A(Cytochrome P-450 CYP3A);药物设计(Drug Design);G蛋白偶联受体激酶2(G-Protein-Coupled Receptor Kinase 2);HEK293细胞(HEK293 Cells);心力衰竭(Heart Failure);高通量筛选分析(High-Throughput Screening Assays);人类(Humans);腙类(Hydrazones);蛋白激酶Cα(Protein Kinase C-alpha);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡啶类(Pyridines);受体, 肾上腺素能β(Receptors, Adrenergic, beta);构效关系(Structure-Activity Relationship);三唑类(Triazoles);rho相关激酶类(rho-Associated Kinases)
DOI
10.1021/acs.jmedchem.7b00443
PMID
28699740
发布时间
2019-08-16
- 浏览7
Journal of medicinal chemistry
6942-6990页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



